(Q35862163)

10 August 2017

1 reference

title

Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial (English)

1 reference

10 August 2017

1 reference

1 reference

Jerry L Bauman

1

1 reference

10 August 2017

Robert L Talbert

series ordinal

2

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

10 August 2017

published in

1 reference

10 August 2017

volume

9

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

117-128

1 reference

Long-Term Trends in the Incidence of and Survival with Heart Failure

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

New epidemiologic perspectives concerning mild-to-moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Mechanisms and models in heart failure: A combinatorial approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

beta-Blocker therapy in heart failure: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Beta-blockers for heart failure: why, which, when, and where.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Pharmacokinetic considerations of formulation: extended-release metoprolol succinate in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Achieving optimal beta1-blockade with metoprolol CR/Zok

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Carvedilol: a review of its use in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Clinical pharmacokinetics and pharmacodynamics of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Extended-Release Metoprolol Succinate in Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

Polymorphic metabolism of metoprolol: clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900207

10.1177/107424840400900207

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference